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ABSTRACT
Objective: Tumour budding formed by histologically
undifferentiated cancer cells beyond the border of the
tumour margin is associated with lymph node
metastasis. However, hollow tumour nests, a possible
histologically advanced phenotype of tumour budding,
have not been discussed. We examined whether
hollow spheroids exist beyond the border of the
invasive margin and are associated with metastasis
and prognosis. Moreover, we suggest that
carcinoembryonic antigen-related cell adhesion
molecule 1 (CEACAM1) isoform balance is associated
with hollow spheroid formation.
Methods: Immunohistochemical analyses with
CEACAM1 and M30 as an apoptosis marker were
performed to examine the importance of hollow spheroid
CEACAM1 expression and central cell apoptosis in
hollow spheroid formation. The correlations between the
presence of hollow spheroids beyond the invasive
margin and the clinicopathological characteristics of 314
patients with colorectal cancer were retrospectively
evaluated. A 3D culture with colorectal cancer cells
transfected with CEACAM1 cDNA or shRNA was used to
determine whether CEACAM1 isoform balance controls
colorectal hollow spheroid formation.
Results: Hollow spheroid formation accompanying
central cell apoptosis was conﬁrmed by M30 staining
and serial section with CEACAM1 staining. Of the 314
patients, 96 (30.4%) were classiﬁed as having hollow
spheroids. The presence of hollow spheroids is an
independent risk factor for metastases and shorter
survival. In 3D culture, CEACAM1 isoform balance
modulated hollow spheroid formation of colorectal
cancer cells.
Conclusions: Hollow spheroid formation beyond the
border of the tumour margin in colorectal cancer is
more important than tumour budding for the
prediction of malignant potential.
INTRODUCTION
An isolated cancer cell or a cancer cluster of
fewer than ﬁve cancer cells was previously
deﬁned as a budding.
1 The correlation
between budding and metastasis and poor
prognosis in colorectal cancer has been
reported.
1e5 It had been shown that tumour
budding was associated with lymphatic inva-
sion and lymph node metastasis in rectal
cancer.
1 It was also reported that tumour
budding was an important predictive factor
for recurrence and poor prognosis in
patients with colorectal cancer.
2 Moreover, it
has been shown that tumour budding was
signiﬁcantly correlated with lymph node
metastasis, local recurrence, distant metas-
tasis and shorter survival in advanced colo-
rectal cancers.
46 e8 However, the progression
of tumour budding, whether an isolated
cancer cell or a cluster of less than ﬁve cancer
cells, has still to be elucidated. Some reports
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ARTICLE SUMMARY
Article focus
- We examine whether hollow spheroids formed by
polarised luminal cells with an inner empty space
exist beyond the tumour margin in colorectal
cancer tissue, and whether the presence of
hollow spheroids correlates with metastasis and
poor prognosis.
- We investigate the role of CEACAM1 in hollow
spheroid formation.
Key messages
- The presence of hollow spheroids beyond the
invasive margin of colorectal cancer is an
independent risk factor for metastases and
shorter survival.
- CEACAM1 isoform balance can modulate hollow
spheroid formation.
Strength and limitations of this study
- This is the ﬁrst report on the existence and
clinical implications of hollow spheroids beyond
the invasive margin of colorectal cancer.
- A validation study is needed for address the
implications of hollow spheroids for colorectal
cancer malignancy.
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Open Access Researchdemonstrated that the histological morphogenesis of
cancer cells can be replicated in 3D culture.
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Accordingly, it is speculated that an isolated cancer cell
progresses to form budding cells, next a spheroid, and
then a hollow spheroid with a lumen. In clinical speci-
mens, hollow spheroids are often regarded as a part of
tube formation and a continuous main tumour. In the
current study, we report that hollow spheroids formed by
polarised luminal cells with an inner empty space exist
beyond the tumour margin in colorectal cancer tissue.
Moreover, we show that the presence of hollow spheroids
is more strongly correlated than tumour budding with
metastasis and poor prognosis.
Carcinoembryonic antigen-related cell adhesion mole-
cule 1 (CEACAM1) plays an important role in this
process, including lumen formation and inner cell
apoptosis in breast cancer cells.
9e12 However, the role of
CEACAM1 in colorectal lumen formation in 3D culture
has not been discussed. CEACAM1 is a type _ trans-
membrane glycoprotein expressed in epithelial cells, and
has three or four extracellular domains and either the
long (71e73 amino acids, CEACAM1-L) or short (8e10
amino acids, CEACAM1-S) cytoplasmic domain isoform.
CEACAM1, previously known as biliary glycoprotein _ or
CD66a, is a member of the carcinoembryonic antigen
family and the immunoglobulin superfamily.
13
CEACAM1 is down-regulated in malignant tissues derived
from the colon,
14 15 liver,
16 breast
17 and prostate,
18
whereas high expression of CEACAM1 is associated with
the progression of gastric cancer,
19 malignant mela-
noma
20 and lung cancer.
21 22 In colorectal cancer, it is
known that down-regulation of CEACAM1 occurs at the
adenoma or early cancer stage,
14 15 and CEACAM1 is re-
expressed in advanced colorectal cancers.
23 24 Recently,
we showed that re-expressed CEACAM1, especially with
long cytoplasmic domain dominance, in advanced colo-
rectal carcinoma is associated with tumour metastasis and
shorter survival.
25 In the present study, we demonstrate
that CEACAM1 isoform balance with long cytoplasmic
domain dominance plays an important role in hollow
spheroid formation in colorectal cancer.
MATERIALS AND METHODS
Patients
Three hundred and fourteen consecutive patients with
colorectal cancer who underwent surgery between
January 2002 and August 2005 in Wakayama Medical
University Hospital (WMUH) were enrolled in the
present study. Forty-six patients had 46 stage I tumours,
125 stage II, 87 stage III, and 56 stage IV based on the
UICC TNM classiﬁcation. The mean age of the patients
was 64.968.3 years, and there were 185 males and 129
females. The tumours were resected from either the
colon (n¼175) or the rectum (n¼129). The follow-up
period was 5 years. Patients with stage III and IV
tumours received postoperative chemotherapy based on
5-ﬂuorouracil, whereas most stage I and II patients
received no chemotherapy.
Immunohistochemistry
Immunohistochemical staining was performed using
parafﬁn-embedded tissue sections. In brief, sections were
de-parafﬁnised and autoclave-treated at 1218C for 7 min
in 0.1 M citrate buffer (pH 6.5). Endogenous peroxidase
activity was blocked by incubation in 10% hydrogen
peroxide for 5 min at room temperature. After washing
with Tris buffer solution and incubation with 5% bovine
serum albumin, the sections were incubated with the
primary monoclonal antibody to 29H2 (ab49510, diluted
1:100; Abcam, Cambridge, MA, USA), CEACAM1-L
polyclonal antibody (diluted 1:1000; Roche Applied
Science, Rotkreuz, Switzerland), CEACAM1-S polyclonal
antibody (diluted 1:1000; Roche) or M30 cytoDEATH
monoclonal antibody (diluted 1:50; Roche) at 48C for
18 h. M30 monoclonal antibody detects caspase-cleaved
cytokeratin 18, which is speciﬁc to apoptotic cells.
26 27
A biotinylated secondary antibody and peroxidase-
conjugated streptavidin were each applied at room
temperature for 90 min. Finally, the sections were incu-
bated in 393-diaminobenzidine for 5 min, followed by
haematoxylin counterstaining and mounting. All speci-
mens were blindly reviewed twice by four individuals
including a pathologist (KT, JI, SY and YN). In case of
difference, the specimen was viewed again using
a multihead microscope and the disagreement resolved
by consensus.
Cells
Two human colorectal cancer cell lines were used in the
present study. LS174T and HT29 cells were purchased
from the American Type Culture Collection (Manassas,
Virginia, USA). LS174Tand HT29 cells were maintained
in Eagle’s Minimum Essential Medium (EMEM; Wako,
Tokyo, Japan) or McCoy’s 5A (Gibco, Grand Island, New
York, USA) medium containing 10% fetal bovine serum
(FBS; Gibco), 100 U/ml of penicillin G, 100 mg/ml
of streptomycin, and 0.25 mg/ml of amphotericin
B (Gibco) at 378C in a 5% humidiﬁed CO2 atmosphere.
Transfection and RNA interference
Transfection of plasmid coding CEACAM1-4L or -4S and
short hairpin RNA (shRNA) plasmids targeted to
CEACAM1 was performed as previously described.
25
Brieﬂy, CEACAM1-4L or -4S cDNA cloned into the pH-
b actin vector
28 (0.8 mg) was mixed with 1 ml of Lipo-
fectamine 2000 (Invitrogen, Carlsbad, California, USA)
in a ﬁnal volume of 100 ml of Opti-MEM medium, and
added to LS174T and HT29 cells grown to 40% conﬂu-
ence in 24-well plates. At 48 h after transfection, G418
(Roche, Basel, Switzerland) was used to isolate stably
transfected cells. Short hairpin RNA plasmids targeted to
CEACAM1 were synthesised by SABiosciences (Fred-
erick, Maryland, USA) as follows: insert sequence CCA
CAA ATG ACA CTG GAA TCT, and gga atc tca ttc gat
gca tac (negative control). Each plasmid (0.8 mg) was
transfected in the same way as outlined above. The
expression level of CEACAM1 was conﬁrmed as
previously described.
25
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Hollow spheroids beyond the invasive margin of colorectal cancerMatrigel culture
Matrigel (200 ml, BD Biosciences, Bedford, MA, USA)
was plated on 24-well plates and allowed to solidify for
15 min at 378C. After the Matrigel solidiﬁed, 0.5 ml of
the cell suspension in the culture medium containing
2310
4 cells/ml was directly seeded into each well and
incubated at 378C in a 5% humidiﬁed CO2 atmosphere
for 2 h. After incubation, Matrigel (200 ml, 50%
concentration) was added to the upper layer and allowed
to solidify for 15 min at 378C. Complete culture medium
was then added, and the plates were incubated at 378Ci n
a 5% humidiﬁed CO2 atmosphere. During culture, cells
were regularly monitored for cell growth and lumen
formation, which was scored by the presence or absence
of a lumen. Culture medium was changed every 3 days
until day 15.
Statistical analysis
The Student t test, the c
2 test or Fisher’s exact test were
used for statistical evaluation, and clinicopathological
factors determined to be signiﬁcant by the c
2 test were
analysed by multivariate logistic regression, and an OR
with 95% CI was calculated for each factor. The
KaplaneMeier method was used to estimate post-
operative survival and the log-rank test was used to
determine statistical signiﬁcance. A Cox proportional
hazards model was used to assess the risk ratio under
simultaneous contributions from several covariates.
p Values of <0.05 were considered to be statistically
signiﬁcant. Statistical calculations were performed using
StatView V5.0 software (SAS Institute).
RESULTS
Hollow spheroids beyond the invasive margin of colorectal
cancer
To clarify that the colorectal cancer nest had a hollow
spheroid structure and that CEACAM1 and central cell
apoptosis were involved in hollow spheroid formation,
we performed immunohistochemistry with CEACAM1
and M30. A ﬁeld with more than one hollow spheroid
beyond the invasive margin was regarded as positive
under 3100 magniﬁcation. Of the 314 parafﬁn-
embedded primary tumour tissue sections stained with
H&E, 96 sections (30.6%) showed cancer nests with
a spheroid hollow beyond the invasive border (ﬁgure 1).
CEACAM1 and CEACAM1-L, but not CEACAM1-S, were
expressed on the luminal inner surface and in the
central apoptotic cells (ﬁgure 1B). The central cells in
the lumen were identiﬁed as apoptotic cells as shown by
M30 staining (ﬁgure 1B). To clarify that the cancer nest
had a hollow spheroid structure, serial 2 mm sections of
parafﬁn-embedded tumour tissue were subjected to
immunohistological examination with CEACAM1
(29H2). The serial colorectal cancer tissue sections
revealed a hollow spheroid structure, and not a tube
formation (ﬁgure 1C). Budding was counted under
3200 magniﬁcation. A ﬁeld with less than ﬁve budding
foci was viewed as negative and a ﬁeld with more than
ﬁve was viewed as positive.
3 A total of 131 sections
(41.7%) were positive for budding at the invasive margin.
Hollow spheroids and the malignant potential of colorectal
cancer
The c
2 test or Fisher’s test for lymph node metastasis
revealed that the presence of hollow spheroids, budding,
depth of tumour invasion, lymphatic permeation, venous
permeation and age >65 were statistically signiﬁcant
(table 1). Multivariate logistic regression analysis for
lymph node metastasis showed that the presence of
hollow spheroids (p<0.001) and lymphatic permeation
(p¼0.001) were independent risk factors (table 2). The
c
2 test or Fisher’s test for distant metastasis revealed that
the presence of hollow spheroids, budding, venous
permeation, lymphatic permeation and depth of tumour
invasion were statistically signiﬁcant (table 1). The
independent risk factors in multivariate logistic regres-
sion analysis for distant metastasis were hollow spheroids
(p<0.001) and budding (p¼0.005) (table 2).
Depth of tumour invasion, lymphatic permeation,
venous permeation, lymph node metastasis, distant
metastasis, budding and hollow spheroids were of
prognostic value for survival in univariate analyses
(table 3). Multivariate analyses with the seven parameters
which in univariate analyses were signiﬁcant regarding
prognosis, revealed that the presence of hollow spher-
oids (p¼0.001) and distant metastasis (p<0.001) were
signiﬁcant independent prognostic factors (table 3).
The KaplaneMeier method used for overall survival
analysis showed that hollow spheroids were signiﬁcantly
associated with shorter survival. The 5-year survival of the
hollow spheroid group was 44.8% compared to 88.9%
for the non-hollow spheroid group (p<0.0001)
(ﬁgure 2A). The 5-year survival of the budding group
was 60.3% compared to 86.3% for the non-budding
group (p<0.0001) (ﬁgure 2B).
Association between CEACAM1 and hollow spheroid
formation
Hollow spheroid formation of CEACAM1-4L or -4S transfected
HT29 cells
Since CEACAM1 is known to have two cytoplasmic
domain isoforms, in order to elucidate the effect of
CEACAM1 overexpression on colorectal cancer hollow
spheroid formation in 3D culture, HT29 cells moder-
ately expressing CEACAM1 were transfected with
a plasmid encoding the CEACAM1-4L or -4S isoform.
Stable CEACAM1-4L or -4S transfected HT29 cells had
signiﬁcantly elevated CEACAM1 mRNA and protein
levels, which was conﬁrmed by RT-PCR and western
blot analyses, respectively, as previously described.
25
CEACAM1-4L transfected HT29 cells formed a lumen,
whereas CEACAM1-4S transfected HT29 cells formed
a solid sphere (ﬁgure 3A). HT29 cells overexpressing
CEACAM1-4L exhibited signiﬁcantly more lumen
formation (p<0.05) (ﬁgure 3B). Conversely, CEACAM1-
4S transfected HT29 cells exhibited signiﬁcantly less
lumen formation (p<0.01) (ﬁgure 3B).
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LS174T cells overexpressing CEACAM1-4L
To address whether CEACAM1 knock-down inhibits
hollow spheroid formation by colorectal cancer cells,
CEACAM1-4L overexpressing LS174T cells were trans-
fected with shRNA against CEACAM1. Stable CEACAM1
shRNA transfected LS174T cells had signiﬁcantly
reduced CEACAM1 mRNA and protein levels, which was
conﬁrmed by RT-PCR and western blot analyses, respec-
tively, as previously described.
25 Vector control trans-
fected LS174T cells formed a lumen, whereas CEACAM1
shRNA silencing LS174T cells formed a solid sphere
(ﬁgure 3A). CEACAM1 knock-down cells exhibited
signiﬁcantly less lumen formation (p<0.01) (ﬁgure 3C).
Hollow spheroid formation of CEACAM1-4S transfected
LS174T cells overexpressing CEACAM1-4L
To determine whether disturbance of CEACAM1 cyto-
plasmic isoform balance affected colorectal cancer
hollow spheroid formation, CEACAM1-4L overexpressing
LS174T cells were transfected with plasmid encoding
CEACAM1-4S. Stable CEACAM1-4S transfected LS174T
Figure 1 Immunohistochemical staining of hollow spheroids in colorectal cancer tissue. (A) Hollow spheroid, (arrows) beyond the
invasive margin expressed CEACAM1 in the luminal surface (29H2) (original magniﬁcation, 3100). (B) The luminal surface and
centre of the lumen were stained with CEACAM1 (left upper, CEACAM1 (29H2); original magniﬁcation, 3400), CEACAM1-L (right
upper, CEACAM1-L speciﬁc antibodies; original magniﬁcation, 3400), CEACAM1-S (left lower, CEACAM1-S speciﬁc antibodies,
staining of endothelial cells and neutrophils were used as an internal positive control; original magniﬁcation, 3400) and M30
cytoDEATH (right lower; original magniﬁcation, 3400). (C) Serial sections (i, ii, iii, iv, v, vi) from top (i) to bottom (vi) of a hollow
spheroid stained with CEACAM1 (29H2). The lumen was a part of the hollow spheroid and was not a tube structure (original
magniﬁcation, 3400).
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Hollow spheroids beyond the invasive margin of colorectal cancercells had signiﬁcantly reduced CEACAM1-4L mRNA and
protein levels, which was conﬁrmed by RT-PCR and
western blot analyses as previously described.
25 The
CEACAM1 and CEACAM1-4L protein levels of these
cells were signiﬁcantly suppressed compared to those of
the parental or vector-transfected cells (control).
25
CEACAM1-4S overexpressing cells reduced the number
of colorectal hollow spheroids formed (p<0.01)
(ﬁgure 3D).
DISCUSSION
Most investigations for colorectal cancer have shown
that tumour budding beyond the invasive margin is
a risk factors for lymph node metastasis.
1 246 e8 In the
present study, hollow spheroids are more correlated
with lymph node involvement, distant metastasis and
overall survival than tumour budding, and multivariate
analysis showed that the presence of hollow spheroids is
an independent risk factor for metastasis and shorter
survival. In particular, multivariate analysis of overall
survival demonstrated that independent predictive
factors for shorter survival are distant metastasis and
hollow spheroids, not tumour budding, indicating that
the presence of hollow spheroids is strongly predictive
of the malignancy of colorectal cancer. We have previ-
ously shown that CEACAM1-L dominance in colorectal
cancer is correlated with shorter survival.
25 In the
present study, we provided data showing that hollow
spheroids expressed CEACAM1-L, not eS, in the
luminal surface, and that their formation is promoted
by CEACAM1-4L expression. KaplaneMeier analysis
demonstrated that the hollow spheroid group had
Table 1 Univariate analyses of lymph node metastasis and distant metastasis
Lymph node metastasis Distant metastasis
Present Absent p Value Present Absent p Value
Age 0.017 0.475
>65 71 74 30 139
<65 60 109 31 114
Gender 0.104 0.389
Male 70 115 39 146
Female 61 68 22 107
Tumour site 0.564 0.084
Colon 72 107 41 138
Rectum 59 76 20 115
Histological type 0.172 0.832
Moderate/well* 125 180 60 245
Othersy 63 1 8
Depth <0.001 <0.001
T3, 4 121 138 61 198
T1, 2 10 45 0 55
Lymphatic permeation <0.001 <0.001
Present 116 96 56 156
Absent 15 87 5 97
Venous permeation <0.001 <0.001
Present 106 105 55 156
Absent 25 78 6 97
Budding <0.001 <0.001
Present 78 53 46 85
Absent 53 130 15 168
Hollow spheroids <0.001 <0.001
Present 72 24 45 51
Absent 59 159 16 202
*Moderate: moderately differentiated adenocarcinoma; well: well differentiated adenocarcinoma.
yOthers: poorly differentiated adenocarcinoma and mucinous adenocarcinoma.
Table 2 Multivariate analyses of lymph node metastasis
and distant metastasis
Variable
No. of
patients OR (95% CI) p Value
Lymph node
metastasis
Lymphatic
permeation
212 4.170
(2.032 to 8.558)
0.001
Hollow spheroid 96 5.407
(2.948 to 9.916)
<0.001
Distant metastasis
Budding 131 2.840
(1.381 to 5.837)
0.005
Hollow spheroid 96 6.334
(3.163 to 12.683)
<0.001
Tamura K, Yokoyama S, Ieda J, et al. BMJ Open 2011;1:e000179. doi:10.1136/bmjopen-2011-000179 5
Hollow spheroids beyond the invasive margin of colorectal cancershorter survival. These results suggested that CEACAM1-
L is involved in hollow spheroid formation leading to
poor prognosis. A cohort validation study is needed to
address the importance of hollow spheroids for colo-
rectal cancer malignancy.
Tumour budding is deﬁned as the presence of indi-
vidual free cells or undifferentiated cancer cells.
1 This
histological structure is also termed ‘sprouting’, ‘focal
dedifferentiation’ or ‘budding’.
16However, it remains
unclear whether tumour budding cells survive or
undergo apoptosis. Based on 3D culture experiments
that replicate the histological morphogenesis of cancer
cells,
91 0it was speculated that surviving and static
dedifferentiated cells proliferate and form spheroids,
followed by central cell apoptosis. In the present study,
we clariﬁed the existence of hollow spheroids beyond
the invasive margin of colorectal cancer, indicating that
the same phenomenon of hollow spheroid formation in
3D culture may also occur in clinical colorectal cancer
tissue. Further investigations are required to determine
if hollow spheroids are derived from tumour budding,
although hollow spheroids do seem to be one of the
advanced forms of tumour budding.
The mRNA level of CEACAM1 was shown to be
down-regulated in colorectal adenoma and early
adenocarcinoma.
14 15 However, some reports have
demonstrated that CEACAM1 protein expression is
upregulated in advanced adenocarcinomas,
23 24 and that
the intensity of CEACAM1 protein expression is corre-
lated with TNM stage
24 but is not signiﬁcantly correlated
with either overall survival or disease-free survival.
23
Recently, we demonstrated that CEACAM1 was re-
expressed at the invasive margin of advanced colorectal
cancers, and that CEACAM1-L dominant expression was
associated with lymph node involvement, distant metas-
tasis and shorter survival.
25 The isoform balance of
CEACAM1 is crucial in the discussion of CEACAM1
function. In the current study, it was demonstrated that
CEACAM1-L, not -S, was expressed on the luminal
surface of hollow spheroids. The result suggested that
CEACAM1-L is involved in hollow spheroid formation
leading to poor prognosis.
Our results showed that CEACAM1-L plays an impor-
tant role in colorectal lumen formation, in contrast to
some reports that breast cancer lumen formation is due
to CEACAM1-S.
10 29 Previous breast cancer studies have
already demonstrated the discrepancy that either long or
short isoforms can promote lumen formation under
different conditions.
10 12 29 30 In 3D culture experi-
ments, CEACAM1-4S mediates lumen formation in
MCF7 breast cancer cells,
10 29 whereas CEACAM1-4L
induced lumen formation in a mouse model.
12 30
Table 3 Univariate and multivariate analyses of survival
Variable
Univariate analysis Multivariate analysis
HR (95% CI) p Value HR (95% CI) p Value
Age (<65) 1.228 (0.785 to 1.919) 0.368
Gender (male) 0.974 (0.618 to 1.536) 0.911
Histologic type (others)* 1.522 (0.480 to 4.828) 0.476
Depth (T3, T4) 9.309 (2.285 to 37.920) 0.002 3.416 (0.793 to 14.727) 0.099
Lymphatic permeation 3.307 (1.746 to 6.262) 0.001 1.024 (0.498 to 2.106) 0.948
Venous permeation 2.200 (1.252 to 3.868) 0.006 0.954 (0.529 to 1.721) 0.876
Lymph node metastasis 4.323 (2.635 to 7.093) <0.001 1.663 (0.951 to 2.909) 0.075
Distant metastasis 9.126 (5.787 to 14.391) <0.001 3.799 (2.251 to 6.413) <0.001
Budding 3.562 (2.209 to 5.743) <0.001 1.302 (0.760 to 2.230) 0.336
Hollow spheroid 6.881 (4.240 to 11.166) <0.001 2.849 (1.632 to 4.975) 0.001
*Others: poorly differentiated adenocarcinoma and mucinous adenocarcinoma.
Figure 2 KaplaneMeier plots of
overall patient survival times. (A)
The survival times of the hollow
spheroid group and the non-hollow
spheroid group were analysed.
The 5-year survival of the hollow
spheroid group was 44.8%
compared to 88.9% for the non-
hollow spheroid group
(p<0.0001). (B) The survival times
of the budding group and the non-
budding group were analysed. The
5-year survival of the budding
group was 60.3% compared to
86.3% for the non-budding group
(p<0.0001).
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Hollow spheroids beyond the invasive margin of colorectal cancerAccording to mutation analysis of CEACAM1-4S cyto-
plasmic domain, phosphorylation of the cytoplasmic
domain is crucial for lumen formation.
12 29 30 Therefore,
both the long and short cytoplasmic domain isoforms of
CEACAM1, according to phosphorylation status, can
induce lumen formation. The molecular mechanism of
CEACAM1 in lumen formation remain to be investigated
in greater detail.
Previous studies have shown that enforced over-
expression of CEACAM1 in normal
9 and cancerous
10
breast cells induced inner cell apoptosis and hollow
spheroid formation in 3D culture and a mouse model.
12
CEACAM1-4S can mediate the reversion of breast cells
from a malignant to a non-malignant morphology with
a well differentiated structure in 3D culture.
10 However,
the association between hollow spheroids in colorectal
cancer and CEACAM1 remains to be elucidated. Our
clinical investigation showed that the luminal surface of
hollow spheroids was stained with CEACAM1-L, but not
the short isoform, and central cell apoptosis of hollow
spheroids was shown by M30 (cleaved cytokeratin 18)
staining. This ﬁnding, that hollow spheroids in colorectal
cancer are formed by central cell apoptosis, is consistent
with the breast cancer 3D culture model. Our 3D culture
experiments showed that enforced CEACAM1-4L
expression of colorectal cancer cells promoted hollow
spheroid formation in 3D culture, and that hollow
spheroid formation was suppressed by shRNA targeted to
CEACAM1. These results indicated that CEACAM1
expression is important for hollow spheroid formation in
colorectal cancer. We also showed that hollow spheroid
formation was inhibited by overexpression of CEACAM1-
4S, indicating that CEACAM1 isoform balance plays an
important role in hollow spheroid formation.
CEACAM1-L contains two tyrosines in immunor-
eceptor-tyrosine-based inhibitory motifs (ITIMs) that can
Figure 3 Morphological changes in colorectal cancer cells in 3D culture and time course of hollow spheroid formation. (A)
CEACAM1-4L transfected HT29 cells (left upper); CEACAM1-4S transfected HT29 cells (right upper); vector control transfected
LS174T cells (left lower); CEACAM1-4S transfected LS174T cells (right lower). (B) CEACAM1-4L and CEACAM1-4S transfected
HT29 cells. (C) CEACAM1 shRNA transfected LS174T cells. (D) CEACAM1-4S transfected LS174T cells. Long: CEACAM1-4L
transfected cells; Parent: parent cells; Short: CEACAM1-4S transfected cells; shRNA: CEACAM1 shRNA transfected cells; Vector:
vector control transfected cells.
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Hollow spheroids beyond the invasive margin of colorectal cancerbe phosphorylated by Src kinases,
31 and once phos-
phorylated, can bind the SHP-1 and SHP-2 phospha-
tases.
32 Two cytoplasmic tyrosines of CEACAM1-L affect
in vivo tumour growth-inhibitory properties and inter-
cellular adhesion.
33 It has been shown that CEACAM1-L
is able to bind actin and tropomyosin, and that
CEACAM1-S can also bind actin, tropomyosin, annexin
__ and calmodulin.
34 In normal colonic epithelial
cells, CEACAM1-L constitutes 15%e20% of the total
CEACAM1 protein.
35 A signiﬁcant overexpression of
the CEACAM1-L isoform or reversion of the normal
ratio of CEACAM1-L/-S isoforms reverses the tumour
inhibition phenotype, whereas CEACAM1-L exhibits
tumour inhibitory potential when the CEACAM1
isoforms are balanced normally.
35 We herein demon-
strated that CEACAM1-4L promoted hollow spheroid
formation in colorectal cancer, while CEACAM1-4S
inhibited hollow spheroid formation. The difference
may be explained by the different functions of the long
and short cytoplasmic domains.
Cytoplasmic domain splicing isoform balance affects
the function of CEACAM1. The balance of CEACAM1
isoform expression has been evaluated in epithelial
cells.
35e37 Both long and short CEACAM1 cytoplasmic
domain isoforms coexist in most normal tissues. The
long isoform is usually expressed in smaller amounts
than the shorter isoform.
35 In normal colonic epithelial
cells, CEACAM1-L accounts for 15%e20% of total
CEACAM1 expressed.
35 The long isoform has a tumour
inhibition phenotype when expressed at physiological
concentrations and in the appropriate ratio relative to
the short isoform. However, signiﬁcant overexpression of
the long isoform or disruption of the normal L/S ratio
abolished the tumour suppressive function.
35 Therefore,
adjustment of the relative ratio of the CEACAM1
isoforms may cause reversion to the normal phenotype.
Although further investigation is required to clarify the
appropriate isoform balance, CEACAM1 splicing control
may be a therapeutic option.
It is important to discuss the function of the carci-
noembryonic antigen (CEA) family in molecular and
cellular biology. It was shown that only carcinoem-
bryonic antigen-related cell adhesion molecule 6
(CEACAM6) expression, and not CEA or CEACAM1, is
an independent prognostic factor for resectable colo-
rectal cancer.
23 Therefore, CEACAM6 may also be
involved in hollow spheroid formation. The association
between hollow spheroid formation and other CEA
family members such as CEACAM6 and CEA remains to
be investigated.
It is speculated that hollow spheroids may form in
glandular sites distant from the original lesion. There-
fore, hollow spheroids may have acquired tumour-initi-
ating properties. Tumour-initiating cells are essential for
tumour growth in a distant lesion. CD133 is one of the
promising tumour-initiating markers. It has been
reported that the CD133-positive cells in colorectal
cancer are tumour initiating and have high tumourigenic
potential.
38 39 Several reports have recently shown that
expression of CD133 correlated with poor prognosis in
colorectal cancer patients.
40 41 We hypothesised that
hollow spheroids at the invasive margin of colorectal
cancers express CD133 as a tumour-initiating marker,
and behave as a tumour-initiating phenotype. In the
immunohistochemical staining of our preliminary
experiments, the staining pattern of CD133 expression
resembled that of CEACAM1 expression, indicating that
there may be a molecular association between CEACAM1
and CD133 (see supplementary data). CD133 expressing
hollow spheroids were observed in all patients with
hollow spheroids, suggesting that some of the
CEACAM1-expressing hollow spheroids may have
tumour-initiating ability. Although further investigation
for other tumour-initiating cell markers is required to
address the association between hollow spheroids and
tumour initiation, hollow spheroids beyond the invasion
margin may be predictive of potent tumour-initiating
growth at metastatic sites.
In conclusion, the present study demonstrated that
hollow spheroids existed beyond the invasive margin and
were an independent risk factor for lymph node
involvement, distant metastases and shorter survival in
patients with colorectal cancer. We also showed that
CEACAM1 isoform balance plays an important role in
central cell apoptosis in hollow spheroids. Identiﬁcation
of hollow spheroids beyond the invasive margin is
important for recognition of the malignant potential of
colorectal cancer.
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